Characterization of rrs and rpsL Mutations in Aminoglycoside-Resistant Mycobacterium tuberculosis Strains Isolated from Clinical Specimens in the West of Iran
Journal of Cellular and Molecular Anesthesia · 2024
DOI: 10.5812/jcma-146643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Anesthesia, 2024. Verfasst von Azadeh Farzamfar und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The medical significance of drug resistance in Mycobacterium tuberculosis, particularly the multi-drug-resistant strains, has a significant impact on the challenge of treating the disease and controlling its prevalence.
Objectives
The objective of this study was to determine the frequency of rrs and rpsL mutations in aminoglycoside-resistant Mycobacterium tuberculosis strains isolated from clinical specimens in western Iran.
Methods
This descriptive cross-sectional study was conducted on positive sputum specimens obtained from 40 pulmonary disease patients referred to the Kermanshah Lung Disease Center. The sputum specimens were cultured on the Löwenstein–Jensen medium. Specimens were assessed for the presence of genes resistant and susceptible to aminoglycosides using gene expression methods. DNA extraction was performed using the G-spin kit, and the Polymerase Chain Reaction (PCR) method and hybridization technique were carried out using the AID kit.
Results
Out of the 40 sputum samples, five (12.5%) were resistant to kanamycin/amikacin, and 12 (30%) showed resistance to streptomycin. Five mutation sites were identified in the codon 1400 of the rrs gene, which were associated with amikacin/kanamycin resistance. Additionally, nine other samples (22.5%) exhibited mutations in the Streptomycin-resistant rpsL A43G gene. Three samples (7.5%) showed mutations in the rrs C526T gene, conferring resistance to streptomycin.
Conclusions
Our investigation revealed a significant frequency of resistance to drugs used as second-line medications. It must be noted that treating patients can be challenging when the frequency of multi-drug-resistant bacteria is high.
Zitieren
APA
Farzamfar, A., Farahani, A., Mohajeri, P., Shamseddin, J., Habibipour, R., & Dastranj, M. (2024). Characterization of rrs and rpsL Mutations in Aminoglycoside-Resistant Mycobacterium tuberculosis Strains Isolated from Clinical Specimens in the West of Iran. Journal of Cellular and Molecular Anesthesia. https://doi.org/10.5812/jcma-146643
Vancouver
Farzamfar A, Farahani A, Mohajeri P, Shamseddin J, Habibipour R, Dastranj M. Characterization of rrs and rpsL Mutations in Aminoglycoside-Resistant Mycobacterium tuberculosis Strains Isolated from Clinical Specimens in the West of Iran. Journal of Cellular and Molecular Anesthesia. 2024. doi:10.5812/jcma-146643
BibTeX
@article{Farzamfar2024,
author = {Farzamfar, Azadeh and Farahani, Abbas and Mohajeri, Parviz and Shamseddin, Jebreil and Habibipour, Reza and Dastranj, Mahsa},
title = {Characterization of rrs and rpsL Mutations in Aminoglycoside-Resistant Mycobacterium tuberculosis Strains Isolated from Clinical Specimens in the West of Iran},
journal = {Journal of Cellular and Molecular Anesthesia},
year = {2024},
doi = {10.5812/jcma-146643}
}
EUVIMED